NLS Research

A new invention to measure the size of protein aggregates (proteins that clump together) can determine very precisely whether a person has systemic lupus erythematosus (SLE) or not and the severity if they have it. The research has been published in the Proceedings of the National Academy of Sciences of the United States of America. “Our […]

Researchers from Karolinska Institutet and the SciLifeLab Chemical Biology Consortium Sweden (CBCS) have identified a chemical compound, CBK77, that has the potential to inhibit protein recycling in cancer cells, subsequently leading to tumor cell death. CBK77 also turned out to have an unexpected advantage, it only affects cells that express the NQO1 enzyme, commonly upregulated […]

Researchers at Karolinska Institutet, Umeå University, and the University of Bonn have identified a new group of molecules that have an antibacterial effect against many antibiotic-resistant bacteria. Since the properties of the molecules can easily be altered chemically, the hope is to develop new, effective antibiotics with few side effects. The findings have been published […]

The human brain, consisting of approximately 86 billion neurons connected by around 100 trillion synapses (Herculano-Houzel, 2009), is in many aspects still a mystery.

One of the receptors discovered by the Nobel Laureates in Medicine is the TRPV1 receptor, which is used by PILA as the leading principle for a novel treatment of diabetes. The 2021 Nobel prize in Physiology or Medicine honors discoveries of receptors for temperature and touch. One of these receptors, the TRPV1 receptor, is thanks […]

AlzeCure Pharma is developing a novel clinical drug candidate for peripheral neuropathic pain, which is based on the seminal discoveries of TRPV1 by Professor Julius, and for which he is awarded the Nobel Prize in Medicine 2021. David Julius has together with Ardem Patapoutian recently been awarded the 2021 Nobel Prize in Physiology or Medicine. […]